CIK 0001746466
- Non-accelerated filer
- Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821554746
- Phone
- +1 858-412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-11 | Thomas Dolca Chief Medical Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 |
Page 1 of 1 · 1 trade